Société Algérienne De Formation Et Recherche En Oncologie

This study observes how a biosimilar version of pertuzumab is used in routine care for HER2-positive breast cancer. It includes 1,000 patients receiving the drug before surgery (neoadjuvant) or as first treatment for advanced disease. Researchers will track treatment patterns, tu…

This study aims to describe the characteristics of 1,000 people with gastric cancer in Algeria, including their demographics, risk factors, symptoms, and how they are diagnosed and treated. By collecting this information, researchers hope to better understand the disease and impr…

This study aims to understand the real-world picture of prostate cancer in Algeria. Researchers will observe 2,000 patients to learn about their backgrounds, how they were diagnosed, and what treatments they receive. The goal is to gather information to help improve future care, …